HEDGE FUND SPHERA
Sphera is a hedge fund specializing in healthcare investment. Its investment strategy is based on extensive industry and trend research, together with a close and ongoing dialogue with portfolio company management teams - who are a significant factor in the investment decision.
Sphera implements various investment tools to hedge portfolio risks, seeking companies with strong fundamentals with the potential to generate sustainable growth.
DR. PINI ORBACH – HEAD OF PHARMA
Dr. Pini Orbach joined Arkin Holdings in February 2010 as Head of its Pharma Division and member of the board in several of its pharmaceutical companies, where he shares his vast hands-on drug development experience. He holds a Ph.D., from the Department of Physiology and Functional Genomics, University of Florida, and was a postdoctoral fellow at the Cardiovascular Research Center, Harvard Medical School - Massachusetts General Hospital.